Index - P/E - EPS (ttm) -2.02 Insider Own 17.33% Shs Outstand 105.04M Perf Week -18.78%
Market Cap 1.96B Forward P/E - EPS next Y -0.99 Insider Trans -0.12% Shs Float 99.61M Perf Month -27.89%
Income -239.78M PEG - EPS next Q -0.34 Inst Own 81.99% Short Float 7.47% Perf Quarter -6.12%
Sales 631.73M P/S 3.10 EPS this Y 37.14% Inst Trans -0.07% Short Ratio 3.92 Perf Half Y -52.94%
Book/sh 6.01 P/B 2.71 EPS next Y 27.98% ROA -24.99% Short Interest 7.44M Perf Year -60.33%
Cash/sh 3.15 P/C 5.15 EPS next 5Y - ROE -31.61% 52W Range 14.02 - 57.90 Perf YTD -70.94%
Dividend Est. - P/FCF - EPS past 5Y -13.04% ROI -29.87% 52W High -71.92% Beta 1.85
Dividend TTM - Quick Ratio 4.42 Sales past 5Y 35.76% Gross Margin 62.48% 52W Low 15.98% ATR (14) 1.56
Dividend Ex-Date - Current Ratio 5.22 EPS Y/Y TTM -35.51% Oper. Margin -30.10% RSI (14) 32.25 Volatility 6.91% 5.99%
Employees 1259 Debt/Eq 0.12 Sales Y/Y TTM 11.14% Profit Margin -37.96% Recom 2.25 Target Price 24.73
Option/Short Yes / Yes LT Debt/Eq 0.11 EPS Q/Q 40.99% Payout - Rel Volume 1.80 Prev Close 15.67
Sales Surprise 2.01% EPS Surprise 33.19% Sales Q/Q 4.28% Earnings Oct 29 AMC Avg Volume 1.90M Price 16.26
SMA20 -22.37% SMA50 -23.83% SMA200 -45.78% Trades
Volume 3,413,383 Change 3.77%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-03-24 Initiated Leerink Partners
Outperform
$35
Jul-22-24 Upgrade Jefferies
Hold → Buy
$24
Jul-18-24 Downgrade JP Morgan
Overweight → Neutral
$40 → $20
Jul-10-24 Downgrade Deutsche Bank
Buy → Hold
$55 → $25
Jun-27-24 Downgrade Wolfe Research
Outperform → Peer Perform
Jun-25-24 Downgrade Guggenheim
Buy → Neutral
Jun-03-24 Resumed Jefferies
Hold
$24
May-01-24 Downgrade TD Cowen
Buy → Hold
$57 → $32
Dec-14-23 Initiated Guggenheim
Buy
$60
Dec-13-23 Initiated Wolfe Research
Outperform
$55
Dec-12-23 Upgrade BofA Securities
Underperform → Neutral
$36 → $54
Jul-05-23 Resumed JP Morgan
Overweight
$65
May-10-23 Initiated Barclays
Overweight
$65
Mar-31-23 Initiated Stephens
Overweight
$65
Feb-02-23 Initiated UBS
Neutral
$50
Dec-14-22 Initiated Deutsche Bank
Buy
$50
Aug-18-22 Downgrade Goldman
Neutral → Sell
$55 → $35
Jul-25-22 Initiated Canaccord Genuity
Buy
$55
Jul-15-22 Downgrade William Blair
Outperform → Mkt Perform
Jul-15-22 Downgrade BofA Securities
Neutral → Underperform
$35
Show Previous Ratings
Oct-10-24 04:14PM
01:26PM
07:36AM
Oct-09-24 05:57PM
04:05PM
05:05PM
Loading…
Oct-04-24 05:05PM
Oct-01-24 04:05PM
(PR Newswire) -5.62%
-5.54%
Sep-10-24 09:00AM
Sep-03-24 04:05PM
Aug-22-24 04:05PM
Aug-12-24 03:01PM
Aug-08-24 06:00PM
05:45PM
04:45PM
(Associated Press Finance)
04:05PM
04:04PM
Loading…
04:04PM
Aug-07-24 09:15AM
Aug-05-24 04:00PM
Aug-01-24 10:01AM
Jul-21-24 11:49PM
Jul-17-24 09:55AM
Jul-12-24 09:15AM
08:00AM
Jul-10-24 02:10PM
Jun-27-24 09:00AM
Jun-25-24 08:14AM
Jun-20-24 09:00AM
Jun-07-24 01:01PM
May-29-24 04:05PM
May-10-24 07:01AM
02:45PM
Loading…
May-07-24 02:45PM
May-06-24 01:04PM
09:08AM
May-02-24 04:05PM
06:04AM
May-01-24 12:59PM
11:33AM
11:05AM
(Thomson Reuters StreetEvents)
03:27AM
01:01AM
Apr-30-24 08:57PM
06:30PM
05:43PM
04:38PM
(Associated Press Finance)
04:05PM
Apr-29-24 11:01AM
Apr-25-24 11:28AM
Apr-24-24 09:35AM
Apr-23-24 10:01AM
Apr-22-24 12:00PM
Apr-18-24 06:46AM
Apr-10-24 04:05PM
Mar-26-24 09:00AM
Mar-21-24 04:05PM
Mar-13-24 04:05PM
08:17AM
Mar-01-24 02:00PM
Feb-27-24 11:55AM
Feb-20-24 04:05PM
Feb-16-24 10:21AM
08:14AM
(Thomson Reuters StreetEvents)
Feb-15-24 06:00PM
05:20PM
04:40PM
04:17PM
(Associated Press Finance)
04:05PM
Feb-08-24 10:00AM
Feb-07-24 04:05PM
Feb-05-24 04:05PM
11:18AM
Jan-30-24 01:03PM
Jan-24-24 04:05PM
Jan-08-24 09:00AM
Dec-21-23 04:05PM
Dec-20-23 04:05PM
Dec-19-23 09:00AM
Dec-13-23 04:26PM
(PR Newswire) +5.26%
+7.75%
Dec-10-23 11:59AM
Dec-07-23 09:00AM
Nov-23-23 11:05AM
Nov-19-23 09:08AM
Nov-17-23 05:22PM
Nov-09-23 01:12AM
Nov-06-23 04:05PM
Nov-03-23 11:09AM
09:14AM
(Thomson Reuters StreetEvents)
Nov-02-23 07:43PM
07:30PM
04:52PM
(Associated Press Finance)
04:05PM
Nov-01-23 04:05PM
Oct-31-23 10:01AM
Oct-30-23 03:45PM
Oct-26-23 04:05PM
Oct-11-23 04:05PM
Oct-10-23 12:06PM
Sep-28-23 08:23AM
Sep-19-23 01:08PM
Sep-18-23 11:52AM
Sep-14-23 04:36PM
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Saxonov Serge Chief Executive Officer Aug 22 '24 Sale 22.53 6,749 152,053 882,467 Aug 26 05:05 PM Hindson Benjamin J. See Remarks Aug 22 '24 Sale 22.53 4,351 98,027 345,704 Aug 26 05:04 PM McAnear Justin J. Former Chief Financial Officer Aug 22 '24 Sale 22.53 2,961 66,710 143,242 Aug 26 05:03 PM Saxonov Serge Officer Aug 22 '24 Proposed Sale 23.01 6,749 155,294 Aug 22 08:45 PM McAnear Justin J. Officer Aug 22 '24 Proposed Sale 23.01 2,961 68,133 Aug 22 08:42 PM Hindson Benjamin J. Officer Aug 22 '24 Proposed Sale 23.01 4,351 100,117 Aug 22 08:39 PM McAnear Justin J. Chief Financial Officer May 22 '24 Sale 24.30 2,936 71,355 146,203 May 23 07:54 PM Saxonov Serge Chief Executive Officer May 22 '24 Sale 24.30 4,877 118,529 889,641 May 23 07:53 PM Hindson Benjamin J. See Remarks May 22 '24 Sale 24.30 4,087 99,329 350,055 May 23 07:52 PM Saxonov Serge Chief Executive Officer Mar 04 '24 Sale 44.00 4,660 205,021 842,900 Mar 06 04:12 PM Saxonov Serge Chief Executive Officer Feb 22 '24 Sale 46.34 2,821 130,737 847,560 Feb 26 04:13 PM Hindson Benjamin J. See Remarks Feb 22 '24 Sale 46.34 2,613 121,098 283,059 Feb 26 04:12 PM McAnear Justin J. Chief Financial Officer Feb 22 '24 Sale 46.34 1,865 86,432 95,240 Feb 26 04:12 PM Saxonov Serge Chief Executive Officer Feb 15 '24 Sale 48.87 5,000 244,332 850,381 Feb 20 04:20 PM Saxonov Serge Chief Executive Officer Feb 09 '24 Sale 49.53 1,000 49,530 855,381 Feb 13 04:56 PM Saxonov Serge Chief Executive Officer Jan 16 '24 Sale 45.24 4,000 180,956 856,381 Jan 18 04:49 PM Hindson Benjamin J. See Remarks Dec 28 '23 Option Exercise 11.48 8,334 95,674 285,672 Dec 29 04:19 PM Saxonov Serge Chief Executive Officer Dec 27 '23 Option Exercise 1.20 14,935 17,922 860,381 Dec 29 04:17 PM Saxonov Serge Chief Executive Officer Dec 14 '23 Sale 55.03 2,000 110,065 845,446 Dec 18 05:43 PM Wilbur James Chief Commercial Officer Nov 22 '23 Sale 43.34 3,464 150,118 83,342 Nov 27 06:18 PM Hindson Benjamin J. See Remarks Nov 22 '23 Sale 43.34 3,449 149,468 277,338 Nov 27 06:16 PM McAnear Justin J. Chief Financial Officer Nov 22 '23 Sale 43.34 1,679 72,762 97,105 Nov 27 06:15 PM Saxonov Serge Chief Executive Officer Nov 22 '23 Sale 43.34 3,757 162,816 851,169 Nov 27 06:15 PM Saxonov Serge Chief Executive Officer Nov 24 '23 Sale 43.72 3,723 162,751 847,446 Nov 27 06:15 PM Wilbur James Chief Commercial Officer Nov 20 '23 Sale 42.09 14,718 619,494 86,806 Nov 22 04:30 PM Saxonov Serge Chief Executive Officer Nov 14 '23 Sale 39.52 2,000 79,041 854,926 Nov 16 04:22 PM Saxonov Serge Chief Executive Officer Oct 17 '23 Sale 39.51 1,979 78,187 856,926 Oct 18 04:33 PM Saxonov Serge Chief Executive Officer Oct 16 '23 Sale 39.50 21 830 858,905 Oct 18 04:33 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
